World's Best Scientists 2026 revealed!
Hildegund C. J. Ertl

Hildegund C. J. Ertl

D-Index & Metrics

Immunology

D-Index
79
Citations
23717
World Ranking
1679
National Ranking
827

Hildegund C. J. Ertl publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hildegund C. J. Ertl sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 325 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hildegund C. J. Ertl D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hildegund C. J. Ertl sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hildegund C. J. Ertl is affiliated with The Wistar Institute in the United States. Their research focuses on the intersection of medicine, immunology, microbiology, and molecular biology, with a substantial emphasis on virus-based gene therapy, infectious diseases, and immunotherapy.

The researcher has contributed extensively to several fields of study, including:

  • Medicine
  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology

Subfields of particular relevance to their work include:

  • Genetics
  • Infectious Diseases
  • Epidemiology
  • Immunology
  • Oncology

Their main research topics cover key areas such as:

  • Virus-based gene therapy research
  • SARS-CoV-2 and COVID-19 Research
  • CAR-T cell therapy research
  • Rabies epidemiology and control
  • Hepatitis B Virus Studies
  • Immunotherapy and Immune Responses
  • Virology and Viral Diseases

Frequent publication venues for the scientist's work include:

  • Journal of Hepatology
  • Human Gene Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Drugs

The scientist has collaborated regularly with several co-authors, notably:

  • Mohadeseh Hasanpourghadi
  • Zhiquan Xiang
  • Mikhail Novikov
  • Dakota Newman
  • Wynetta Giles-Davis

Among their recent papers are:

  • Immunogenicity and toxicity of AAV gene therapy, 2022, Frontiers in Immunology
  • T Cell-Mediated Immune Responses to AAV and AAV Vectors, 2021, Frontiers in Immunology
  • Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways, 2021, Cell Reports Medicine
  • Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection, 2022, Journal of Hepatology
  • Towards rabies elimination in the Asia-Pacific region: From theory to practice, 2020, Biologicals

Best Publications

  • Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Manno Cs;Pierce Gf;Arruda Vr;Glader B

  • MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses

    Yiping Yang;Yiping Yang;Hildegund C.J. Ertl;James M. Wilson

  • CD8(+) T-cell responses to adeno-associated virus capsid in humans.

    Federico Mingozzi;Marcela V Maus;Marcela V Maus;Daniel J Hui;Denise E Sabatino

  • Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

    Zhiquan Xiang;Hildegund C.J. Ertl

  • Enhancing CD8 + T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy.

    Ying Zhang;Ying Zhang;Raj Kurupati;Ling Liu;Xiang Yang Zhou

  • Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

    Y. Yang;K. U. Jooss;Q. Su;H. C. J. Ertl

  • Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

    Zhi Quan Xiang;Steven Spitalnik;Minh Tran;William H. Wunner

  • Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo

    Yiping Yang;Zhiquan Xiang;Hildegund C. J. Ertl;James M. Wilson

  • New Insights on Adenovirus as Vaccine Vectors

    Marcio O Lasaro;Hildegund C J Ertl

  • A REPLICATION-DEFECTIVE HUMAN ADENOVIRUS RECOMBINANT SERVES AS A HIGHLY EFFICACIOUS VACCINE CARRIER

    Zhi Quan Xiang;Yiping Yang;Yiping Yang;James M. Wilson;James M. Wilson;Hildegund C.J. Ertl

  • Replication-Defective Vector Based on a Chimpanzee Adenovirus

    Steven F. Farina;Guang-ping Gao;Z. Q. Xiang;John J. Rux

  • Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus Vectors

    Kimberly McCoy;Nia Tatsis;Birgit Korioth-Schmitz;Marcio O. Lasaro

  • A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

    Julie C. Fitzgerald;Guang-Ping Gao;Arturo Reyes-Sandoval;Arturo Reyes-Sandoval;George N. Pavlakis

  • Random migration precedes stable target cell interactions of tumor-infiltrating T cells

    Paulus Mrass;Hajime Takano;Lai Guan Ng;Sachin Daxini

  • The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9–dependent innate immune responses in the liver

    Ashley T. Martino;Masataka Suzuki;David M. Markusic;Irene Zolotukhin

  • Immune Responses to Nucleic Acid Vaccines to Rabies Virus

    Zhi Quan Xiang;Steve L. Spitalnik;Jun Cheng;Jan Erikson

  • Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines

    Nia Tatsis;Julie C. Fitzgerald;Julie C. Fitzgerald;Arturo Reyes-Sandoval;Arturo Reyes-Sandoval;Kimberly C. Harris-McCoy

  • Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein

    Bernhard Dietzschold;Honghai Wang;Charles E. Rupprecht;Esteban Celis

  • Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product

    Zhiquan Xiang;Guangping Gao;Arturo Reyes-Sandoval;Christopher J. Cohen

  • Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.

    Ulrich H. Koszinowski;H. Ertl

Frequent Co-Authors

Katherine A. High
Katherine A. High Children's Hospital of Philadelphia
Laszlo Otvos
Laszlo Otvos Semmelweis University
James M. Wilson
James M. Wilson University of Pennsylvania
Kenneth E. Schmader
Kenneth E. Schmader Duke University
Ralf Hoffmann
Ralf Hoffmann Leipzig University
Michael R. Betts
Michael R. Betts University of Pennsylvania
Federico Mingozzi
Federico Mingozzi Children's Hospital of Philadelphia
Yiping Yang
Yiping Yang The Ohio State University
E. John Wherry
E. John Wherry University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees such as nursing specialties can open diverse career opportunities. Many professionals pursue advanced practice roles by enrolling in programs like the best psychiatric mental health nurse practitioner programs online, which offer strong clinical placements to gain hands-on experience.

Cost is often a consideration when choosing a program. Students looking for affordable options may find value in the cheapest pmhnp programs online without compromising quality, helping them start their careers with less financial burden.

Understanding compensation trends post-graduation is also crucial. Resources detailing dnp salary transparency provide insights into expected earnings by state, aiding in informed career planning for nurse practitioners and DNP-prepared professionals.

Additionally, for those already in the nursing field, transitioning roles through programs such as the fnp to acnp bridge program online can be an effective pathway toward specialization in acute care settings, complementing knowledge in immunology and advancing clinical expertise.

Best Scientists Citing Hildegund C. J. Ertl

Trending Scientists

Recently Published Articles